Works matching Cancer vaccines
Results: 5000
Manufacturing and Financial Evaluation of Peptide-Based Neoantigen Cancer Vaccines for Triple-Negative Breast Cancer in the United Kingdom: Opportunities and Challenges.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 144, doi. 10.3390/vaccines13020144
- By:
- Publication type:
- Article
Manufacturing and Financial Evaluation of Peptide-Based Neoantigen Cancer Vaccines for Triple-Negative Breast Cancer in the United Kingdom: Opportunities and Challenges.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 144, doi. 10.3390/vaccines13020144
- By:
- Publication type:
- Article
Cancer vaccines: an update on recent achievements and prospects for cancer therapy.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 25, n. 1, p. 1, doi. 10.1007/s10238-024-01541-7
- By:
- Publication type:
- Article
Personalized cancer vaccine design using AI-powered technologies.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1357217
- By:
- Publication type:
- Article
AutoEpiCollect, a Novel Machine Learning-Based GUI Software for Vaccine Design: Application to Pan-Cancer Vaccine Design Targeting PIK3CA Neoantigens.
- Published in:
- Bioengineering (Basel), 2024, v. 11, n. 4, p. 322, doi. 10.3390/bioengineering11040322
- By:
- Publication type:
- Article
Next Generation Cancer Vaccines—Make It Personal!.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 52, doi. 10.3390/vaccines6030052
- By:
- Publication type:
- Article
Novel Methodology for the Design of Personalized Cancer Vaccine Targeting Neoantigens: Application to Pancreatic Ductal Adenocarcinoma.
- Published in:
- Diseases, 2024, v. 12, n. 7, p. 149, doi. 10.3390/diseases12070149
- By:
- Publication type:
- Article
Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1246682
- By:
- Publication type:
- Article
Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3679, doi. 10.1007/s00262-021-03024-0
- By:
- Publication type:
- Article
Advances in mRNA-Based Cancer Vaccines.
- Published in:
- Vaccines, 2023, v. 11, n. 10, p. 1599, doi. 10.3390/vaccines11101599
- By:
- Publication type:
- Article
Current Development of Therapeutic Vaccines in Lung Cancer.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 185, doi. 10.3390/vaccines13020185
- By:
- Publication type:
- Article
Current Development of Therapeutic Vaccines in Lung Cancer.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 185, doi. 10.3390/vaccines13020185
- By:
- Publication type:
- Article
Application of machine learning and deep learning for cancer vaccine (rapid review).
- Published in:
- Multimedia Tools & Applications, 2024, v. 83, n. 17, p. 51211, doi. 10.1007/s11042-023-17589-8
- By:
- Publication type:
- Article
Virus like particles as a platform for cancer vaccine development.
- Published in:
- PeerJ, 2017, n. 11, p. 1, doi. 10.7717/peerj.4053
- By:
- Publication type:
- Article
Therapeutic Cancer Vaccines in Prostate Cancer: The Paradox of Improved Survival Without Changes in Time to Progression.
- Published in:
- Oncologist, 2010, v. 15, n. 9, p. 969, doi. 10.1634/theoncologist.2010-0129
- By:
- Publication type:
- Article
Recent Findings on Therapeutic Cancer Vaccines: An Updated Review.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 4, p. 503, doi. 10.3390/biom14040503
- By:
- Publication type:
- Article
Natural killer cells as helper cells in dendritic cell cancer vaccines.
- Published in:
- Frontiers in Immunology, 2015, v. 5, p. 1, doi. 10.3389/fimmu.2015.00013
- By:
- Publication type:
- Article
Exosomes derived from tumor cells genetically modified to express Mycobacterium tuberculosis antigen: a novel vaccine for cancer therapy.
- Published in:
- Biotechnology Letters, 2016, v. 38, n. 11, p. 1857, doi. 10.1007/s10529-016-2185-1
- By:
- Publication type:
- Article
Effects of Cancer Cell-Derived Nanovesicle Vaccines Produced by the Oxidative Stress-Induced Expression of DAMP and Spontaneous Release/Filter Extrusion in the Interplay of Cancer Cells and Macrophages.
- Published in:
- Biomedicines, 2022, v. 10, n. 8, p. N.PAG, doi. 10.3390/biomedicines10081977
- By:
- Publication type:
- Article
Cancer Vaccines and Oncolytic Viruses Exert Profoundly Lower Side Effects in Cancer Patients than Other Systemic Therapies: A Comparative Analysis.
- Published in:
- Biomedicines, 2020, v. 8, n. 3, p. 61, doi. 10.3390/biomedicines8030061
- By:
- Publication type:
- Article
Reader-free ELISPOT assay for immuno-monitoring in peptide-based cancer vaccine immunotherapy.
- Published in:
- Biomedical Reports, 2020, v. 12, n. 5, p. 244, doi. 10.3892/br.2020.1289
- By:
- Publication type:
- Article
Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00008
- By:
- Publication type:
- Article
Cancer vaccines as promising immuno-therapeutics: platforms and current progress.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01247-x
- By:
- Publication type:
- Article
肿瘤治疗性疫苗的研发现状与展望.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2023, v. 30, n. 7, p. 541, doi. 10.3872/j.issn.1007-385x.2023.07.001
- By:
- Publication type:
- Article
Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors.
- Published in:
- Cancer Biology & Medicine, 2015, v. 12, n. 3, p. 201, doi. 10.7497/j.issn.2095-3941.2015.0046
- By:
- Publication type:
- Article
Cancer Vaccine Therapeutics: Limitations and Effectiveness—A Literature Review.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 17, p. 2159, doi. 10.3390/cells12172159
- By:
- Publication type:
- Article
In Silico Model Estimates the Clinical Trial Outcome of Cancer Vaccines.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 11, p. 3048, doi. 10.3390/cells10113048
- By:
- Publication type:
- Article
IL-7: A promising adjuvant ensuring effective T cell responses and memory in combination with cancer vaccines?
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1022808
- By:
- Publication type:
- Article
Characteristics of clinical trials for non-small cell lung cancer therapeutic vaccines registered on ClinicalTrials.gov.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.936667
- By:
- Publication type:
- Article
MuSyC dosing of adjuvanted cancer vaccines optimizes antitumor responses.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.936129
- By:
- Publication type:
- Article
Potential association factors for developing effective peptide-based cancer vaccines.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.931612
- By:
- Publication type:
- Article
Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.826164
- By:
- Publication type:
- Article
S-540956, a CpG Oligonucleotide Annealed to a Complementary Strand With an Amphiphilic Chain Unit, Acts as a Potent Cancer Vaccine Adjuvant by Targeting Draining Lymph Nodes.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.803090
- By:
- Publication type:
- Article
Cancer vaccines: current status and future directions.
- Published in:
- Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01670-w
- By:
- Publication type:
- Article
Therapeutic cancer vaccine: building the future from lessons of the past.
- Published in:
- Seminars in Immunopathology, 2019, v. 41, n. 1, p. 69, doi. 10.1007/s00281-018-0691-z
- By:
- Publication type:
- Article
Genetically modified cancer vaccines: Current status and future prospects.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 4, p. 1492, doi. 10.1002/med.21882
- By:
- Publication type:
- Article
RNA modification in mRNA cancer vaccines.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 6, p. 1917, doi. 10.1007/s10238-023-01020-5
- By:
- Publication type:
- Article
Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1147590
- By:
- Publication type:
- Article
Pre-vaccination transcriptomic profiles of immune responders to the MUC1 peptide vaccine for colon cancer prevention.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1437391
- By:
- Publication type:
- Article
Nucleic acid cancer vaccines targeting tumor related angiogenesis. Could mRNA vaccines constitute a game changer?
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1433185
- By:
- Publication type:
- Article
Immunogenic cell death-based cancer vaccines: promising prospect in cancer therapy.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1389173
- By:
- Publication type:
- Article
Potential and development of cellular vesicle vaccines in cancer immunotherapy.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-01781-3
- By:
- Publication type:
- Article
WT1 epitope-specific IgG and IgM antibodies for immune-monitoring in patients with advanced sarcoma treated with a WT1 peptide cancer vaccine.
- Published in:
- Oncology Letters, 2022, v. 23, n. 2, p. N.PAG, doi. 10.3892/ol.2022.13184
- By:
- Publication type:
- Article
Quantitative analysis and clonal characterization of T-cell receptor β repertoires in patients with advanced non-small cell lung cancer treated with cancer vaccine.
- Published in:
- Oncology Letters, 2017, v. 14, n. 1, p. 283, doi. 10.3892/ol.2017.6125
- By:
- Publication type:
- Article
mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy.
- Published in:
- Biomarker Research, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40364-024-00692-9
- By:
- Publication type:
- Article
mRNA vaccine in cancer therapy: Current advance and future outlook.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 8, p. 1, doi. 10.1002/ctm2.1384
- By:
- Publication type:
- Article
Toxicity of a GM3 cancer vaccine in Macaca fascicularis monkey: a 12-month study.
- Published in:
- Human & Experimental Toxicology, 2002, v. 21, n. 5, p. 263, doi. 10.1191/0960327102ht248oa
- By:
- Publication type:
- Article
Status of and prospects for cancer vaccines against hepatocellular carcinoma in clinical trials.
- Published in:
- BioScience Trends, 2016, v. 10, n. 2, p. 85, doi. 10.5582/bst.2015.01128
- By:
- Publication type:
- Article
Injectable Mesocellular Foam Silica Microparticles with a Dual Role of Cell‐Recruiting Scaffolds and Intracellular Delivery Vehicles for Enhanced Cancer Vaccine.
- Published in:
- Advanced Functional Materials, 2024, v. 34, n. 25, p. 1, doi. 10.1002/adfm.202316133
- By:
- Publication type:
- Article
Therapeutic metastatic prostate cancer vaccines: lessons learnt from urologic oncology.
- Published in:
- Central European Journal of Urology (2080-4806), 2021, v. 74, n. 3, p. 300, doi. 10.5173/ceju.2021.0094
- By:
- Publication type:
- Article